Metal-Coordination Directs the Self-Assembly of Terpyridine-Peptide Conjugates into Multifunctional Nanoplatforms with Potent In Vitro Antitumor Effects
Source abstract
Abstract
The complexity of cancer treatment calls for multimodal nanoplatforms integrating multiple therapeutic functions. Herein, we design a metal-ion-directed self-assembly strategy using a terpyridine-functionalized peptide (TyD) and demonstrate that coordination with different metal ions (Cu 2+, Mn 2+, Fe 2+ ) simultaneously regulates nanostructure formation and dictates their enzyme-mimetic, DNA-binding, and photothermal properties. Notably, the TyD-Cu 2+ complex emerged as a uniquely multifunctional platform, enabling efficient reactive oxygen species (ROS) generation, glutathione (GSH) depletion, DNA binding and cleavage, and exhibiting a high photothermal conversion efficiency (η = 33%). Relying on these integrated, metal-ion-dependent functionalities, we constructed a nanoplatform that synergistically combines chemodynamic therapy, photothermal therapy, and DNA-damaging interventions. This work establishes a metal-ion-tunable strategy for creating multifunctional peptide-based nanomaterials with potent antitumor effects in vitro, offering a promising material platform for further development in cancer therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Supramolecular Self-Assembly in Materials · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Chemistry, Chemical Engineering and Materials Science
Soochow University
State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions
Funding
Jiangsu Engineering Laboratory of Novel Functional Polymeric Materials, Soochow University
References (58)
Show source-provided references
1. 10.1038/s41573-022-00615-z10.1038/s41573-022-00615-z ↗
2. 10.1007/s12672-025-02198-810.1007/s12672-025-02198-8 ↗
3. 10.1038/s41591-023-02655-310.1038/s41591-023-02655-3 ↗
4. 10.1002/adhm.20240269710.1002/adhm.202402697 ↗
5. 10.1016/j.ccr.2024.21596910.1016/j.ccr.2024.215969 ↗
6. 10.1002/advs.20230620310.1002/advs.202306203 ↗
7. 10.1039/D2CS00757F10.1039/D2CS00757F ↗
8. 10.1002/adma.20241612210.1002/adma.202416122 ↗
9. 10.1016/j.cej.2022.13477810.1016/j.cej.2022.134778 ↗
10. 10.1002/asia.20230102010.1002/asia.202301020 ↗
11. 10.1021/jacs.5c0485710.1021/jacs.5c04857 ↗
12. 10.1038/s41467-025-61175-510.1038/s41467-025-61175-5 ↗
13. 10.1039/D4RA04119D10.1039/D4RA04119D ↗
14. 10.1016/j.ccr.2023.21561910.1016/j.ccr.2023.215619 ↗
15. 10.1016/j.ccr.2023.21538010.1016/j.ccr.2023.215380 ↗
16. 10.1038/s41467-021-25303-110.1038/s41467-021-25303-1 ↗
17. 10.1016/j.ijbiomac.2024.13279210.1016/j.ijbiomac.2024.132792 ↗
18. 10.3389/fchem.2020.0021010.3389/fchem.2020.00210 ↗
19. 10.1021/acsnano.2c0571510.1021/acsnano.2c05715 ↗
20. 10.1039/C9QI00081J10.1039/C9QI00081J ↗
21. 10.1002/adma.20231143710.1002/adma.202311437 ↗
22. 10.1039/D5SC06054K10.1039/D5SC06054K ↗
23. 10.1039/D5PY00315F10.1039/D5PY00315F ↗
24. 10.1039/D0CS00654H10.1039/D0CS00654H ↗
25. 10.1002/adhm.20200121110.1002/adhm.202001211 ↗
26. 10.1021/jacs.8b0491210.1021/jacs.8b04912 ↗
27. 10.1016/j.ejmech.2023.11611910.1016/j.ejmech.2023.116119 ↗
28. 10.1002/asia.20250092010.1002/asia.202500920 ↗
29. 10.1002/anie.20200629010.1002/anie.202006290 ↗
30. 10.1021/jacs.2c1182310.1021/jacs.2c11823 ↗
31. 10.1002/anie.20171023710.1002/anie.201710237 ↗
32. 10.1002/agt2.67210.1002/agt2.672 ↗
33. 10.1039/D2RA02771B10.1039/D2RA02771B ↗
34. 10.1016/j.jddst.2024.10592410.1016/j.jddst.2024.105924 ↗
35. 10.1021/jacs.6b1232210.1021/jacs.6b12322 ↗
36. 10.1038/s41573-024-00979-410.1038/s41573-024-00979-4 ↗
37. 10.1021/acsnano.3c0777510.1021/acsnano.3c07775 ↗
38. 10.1021/acsabm.5c0253310.1021/acsabm.5c02533 ↗
39. 10.1021/acs.molpharmaceut.4c0088310.1021/acs.molpharmaceut.4c00883 ↗
40. 10.1039/D2DT00613H10.1039/D2DT00613H ↗
41. 10.1002/adma.20160196010.1002/adma.201601960 ↗
42. 10.3389/fchem.2020.0083010.3389/fchem.2020.00830 ↗
43. 10.1039/D2DT02410A10.1039/D2DT02410A ↗
44. 10.1002/psc.364810.1002/psc.3648 ↗
45. 10.1016/j.nantod.2021.10107610.1016/j.nantod.2021.101076 ↗
46. 10.1002/adfm.20210358110.1002/adfm.202103581 ↗
47. 10.1016/j.ccr.2025.21680510.1016/j.ccr.2025.216805 ↗
48. 10.1039/D2TA09039B10.1039/D2TA09039B ↗
49. 10.1016/j.partic.2023.03.00910.1016/j.partic.2023.03.009 ↗
50. 10.1039/D5NJ02354H10.1039/D5NJ02354H ↗
51. 10.1002/anie.20220284310.1002/anie.202202843 ↗
52. 10.1002/smll.20250320810.1002/smll.202503208 ↗
53. 10.1021/acsmaterialslett.4c0242310.1021/acsmaterialslett.4c02423 ↗
54. 10.1039/D3CS00227F10.1039/D3CS00227F ↗
55. 10.1016/j.molstruc.2023.13575110.1016/j.molstruc.2023.135751 ↗
56. 10.1016/j.jinorgbio.2021.11162410.1016/j.jinorgbio.2021.111624 ↗
57. 10.1039/D0TB01274B10.1039/D0TB01274B ↗
58. 10.1021/acs.biochem.0c0028010.1021/acs.biochem.0c00280 ↗